Home > Boards > US Listed > Medical - Drugs > BIOFRONTERA AG (BFRA)

Biofrontera AG announces subscription price for 1.00 %

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Leebarooski Member Profile
 
Followed By 29
Posts 936
Boards Moderated 0
Alias Born 08/08/10
160x600 placeholder
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 4/12/2021 5:31:42 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/12/2021 5:17:13 PM
Biofrontera reports Q4 results Seeking Alpha - 4/12/2021 2:05:15 PM
Biofrontera reports results for the 2020 financial year GlobeNewswire Inc. - 4/12/2021 1:57:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/8/2021 2:19:40 PM
Biofrontera provides preliminary revenue for 1Q21 Seeking Alpha - 4/8/2021 1:49:44 PM
Biofrontera announces preliminary revenue for Q1 2021 GlobeNewswire Inc. - 4/8/2021 10:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/31/2021 1:54:09 PM
Biofrontera announces conference call to be held on April 13, 2021 to discuss fiscal year 2020 financial results GlobeNewswire Inc. - 3/31/2021 10:12:43 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/31/2021 6:18:52 AM
Biofrontera submits application for FDA approval of new BF-RhodoLEDĀ® XL lamp GlobeNewswire Inc. - 3/31/2021 3:40:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/30/2021 7:22:17 AM
Humanigen, Universe Pharmaceuticals leads healthcare gainers; Millendo Therapeutics, Orphazyme among major losers Seeking Alpha - 3/29/2021 11:00:25 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/16/2021 6:22:23 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/4/2021 6:07:29 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/3/2021 2:53:12 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/3/2021 2:49:56 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/1/2021 1:10:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/26/2021 5:03:36 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/26/2021 10:29:20 AM
Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million GlobeNewswire Inc. - 2/26/2021 9:20:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/25/2021 4:28:11 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 2/25/2021 4:06:58 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/25/2021 3:35:03 PM
Leebarooski   Tuesday, 08/11/20 08:04:48 PM
Re: Leebarooski post# 13
Post # of 25 
Biofrontera AG announces subscription price for 1.00 % qualified subordinated mandatory convertible bond 2020/2021
Leverkusen, Aug. 10, 2020 (GLOBE NEWSWIRE) -- The Executive Board of Biofrontera AG (shares of Biofrontera AG ISIN: DE0006046113) has decided on 27 July 2020, with the approval of the Supervisory Board, to issue a 1.00 % qualified subordinated mandatory convertible bond 2020/2021 (ISIN: DE000A3E4548 / WKN: A3E454). It is divided into up to 2,638,150 qualified subordinated mandatory convertible bearer bonds ("Bonds") with a nominal value of EUR 3.00 each and a total nominal value

Aug 10, 2020

www.globenewswire.com

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences